Clinical article · Acute care, Specialties, Women, children and mental health

First-episode psychosis: the medical work-up and the first weeks of treatment

Written for
Emergency doctors, physicians, psychiatry residents and liaison teams
Reading time
7 minutes
Published
Updated

Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.

Key points

  • A first episode of psychosis needs a medical assessment before a primary psychiatric diagnosis is accepted.
  • Acute onset, fluctuating attention, visual hallucinations, abnormal vital signs, seizures, abnormal movements and new neurological signs point towards an organic cause.
  • Autoimmune encephalitis, particularly anti-NMDA receptor encephalitis, can begin with psychiatric symptoms alone; an international consensus sets out when and how to test.
  • Baseline tests do two jobs: they look for secondary causes and prepare for safe antipsychotic treatment.
  • Shortening the duration of untreated psychosis and referring early to an early intervention service are priorities.
  • Start antipsychotics low, choose by side-effect profile with the patient, and monitor weight, glucose, lipids and movement disorders from the start.

Primary or secondary psychosis

Psychosis is a syndrome, not a diagnosis. Most first episodes prove to be primary psychotic or affective disorders, but a minority have a medical, neurological or drug-related cause that needs different treatment. Assessment starts with a careful history, examination and a work-up that is guided by the clinical picture rather than a fixed list [1]. The main groups of secondary causes are:

GroupExamplesClues
DeliriumInfection, metabolic disturbance, hypoxia, after surgeryFluctuating attention, disorientation, visual hallucinations, older age
SubstancesCannabis, stimulants, hallucinogens, alcohol or sedative withdrawalTiming of use; cannabis shows a dose-response association with psychosis [6]
MedicinesCorticosteroids, dopaminergic and anticholinergic drugs, some antimicrobials and antiepilepticsA new drug or dose change before onset
NeurologicalTemporal lobe epilepsy, tumour, stroke, demyelination, neurodegenerative diseaseSeizures, focal signs, cognitive decline, abnormal movements
Autoimmune and inflammatoryAnti-NMDA receptor and other autoimmune encephalitides, systemic lupus erythematosusRapid onset, catatonia, seizures, dyskinesia, autonomic instability [3, 4]
Endocrine, metabolic and infectiveThyroid disease, hypercalcaemia, hyponatraemia, Wilson disease, vitamin B12 deficiency, HIV, syphilis, viral encephalitisSystemic symptoms, abnormal results, risk factors

History and examination

Establish the speed of onset and any prodrome, a detailed substance history including the type and frequency of cannabis use, every prescribed and over-the-counter medicine, head injury, seizures, recent infection, family history and pregnancy. A collateral history from family is often decisive. Examine fully, including temperature and vital signs, signs of intoxication or withdrawal, a neurological examination, catatonic features and abnormal movements, and test attention and cognition rather than assuming them to be normal.

  • Onset over hours or days, or fluctuating consciousness or attention
  • Visual, tactile or olfactory hallucinations as the dominant feature
  • Fever, tachycardia, autonomic instability or abnormal vital signs
  • Seizures, headache, focal neurological signs, dyskinesia or catatonia
  • First onset in later life, or a sudden change in someone with a stable psychiatric illness
  • Marked sensitivity to antipsychotics, such as severe rigidity after a small dose

Any of these features should prompt a search for an organic cause, often with medical or neurology input, before a primary psychiatric diagnosis is made.

Baseline investigations

  • Full blood count, urea and electrolytes, calcium, liver and thyroid function, glucose or HbA1c, and lipids
  • Urine drug screen, and a pregnancy test where relevant
  • Tests for HIV and syphilis, and vitamin B12 and folate where indicated
  • Weight, waist circumference, blood pressure and pulse, recorded before antipsychotic treatment
  • An ECG, particularly with cardiac risk factors or before drugs that prolong the QT interval
  • Prolactin as a baseline where the antipsychotic chosen raises it

Imaging, EEG and lumbar puncture

Whether every patient with first-episode psychosis needs brain MRI is debated. It has been argued that MRI should be mandatory because missing a secondary cause has serious consequences, but the question remains controversial partly because the prevalence of clinically relevant abnormalities has been uncertain, which a 2023 meta-analysis set out to estimate [2]. Services vary between routine MRI and imaging targeted by clinical features; image whenever the history or examination suggests an organic cause.

EEG is indicated for seizures, fluctuating consciousness, catatonia or suspected encephalitis. Anti-NMDA receptor encephalitis can present with rapidly progressive psychiatric symptoms, is difficult to distinguish from a primary psychiatric disorder at onset, often requires intensive care, and is more common in women [4]. Immune-mediated psychoses typically begin acutely with polymorphic symptoms, with neurological features appearing later [5]. An international consensus describes when to test serum and cerebrospinal fluid for neuronal antibodies and how to approach psychosis of suspected autoimmune origin [3]. Lumbar puncture and antibody testing are planned with neurology.

The first weeks of treatment

A longer duration of untreated psychosis has been associated with poorer outcomes [7], and a 2024 meta-analysis examined how early detection and intervention strategies change it and real-world outcomes [8]. Refer early to an early intervention in psychosis service. In the RAISE-ETP study, a comprehensive first-episode programme produced better quality of life and fewer psychotic and depressive symptoms than usual community care [12].

  1. Choose the antipsychotic with the patient, by side-effect profile, comorbidity and preference; no single drug is best for everyone, and comparative efficacy and tolerability in first episodes have been reviewed in a network meta-analysis [9].
  2. Start at a low dose and titrate slowly, because people in a first episode often respond to lower doses and are more sensitive to adverse effects; avoid high doses and combinations of antipsychotics.
  3. Monitor weight, glucose, lipids, blood pressure, prolactin-related symptoms, extrapyramidal effects and akathisia from the first weeks, following a recognised guideline such as that of the British Association for Psychopharmacology [11] or the international INTEGRATE algorithm [10].
  4. Use a benzodiazepine for short-term agitation or insomnia if needed, and treat catatonia as a medical emergency in its own right.
  5. Offer psychological and family interventions and support with education, work and housing alongside medication.

Traps

  • Accepting a label of medically cleared without an examination or a review of results.
  • Diagnostic overshadowing, in which physical symptoms are attributed to the psychiatric illness.
  • Attributing psychosis entirely to cannabis without considering other causes.
  • Missing delirium in an older patient with new hallucinations.
  • Mistaking akathisia for agitation and increasing the antipsychotic dose.
  • Starting valproate or other teratogenic drugs without considering pregnancy.

Capacity, consent and the use of mental health legislation depend on the jurisdiction. Follow the local legal framework and early intervention protocol.

How Sana Health helps

The Mental Health engine starts with immediate safety, then works through the physical and drug-related causes to exclude before a primary psychiatric diagnosis is accepted, including delirium, intoxication, medication effects and autoimmune encephalitis. It proposes a work-up matched to the presentation, applies DSM-5-TR or ICD-11 criteria, and gives prescribing advice with starting dose, titration, time to effect and monitoring. A risk formulation and safety plan follow the conclusion, and the report ends with numbered PubMed references and US product labels for the named drugs.

Questions

Does every patient with first-episode psychosis need an MRI brain?

Practice varies. Some services image everyone, others reserve MRI for patients with neurological signs, atypical features or late onset, and the yield has been the subject of a recent meta-analysis. Follow the local early intervention protocol, and image whenever the history or examination suggests an organic cause.

When should autoimmune encephalitis be considered in psychosis?

When psychosis begins acutely and is accompanied by reduced consciousness, seizures, abnormal movements, catatonia, autonomic instability, marked sensitivity to antipsychotics, a recent viral illness or focal neurological signs. An international consensus describes a staged approach to antibody testing in serum and cerebrospinal fluid, with neurology input.

What is the duration of untreated psychosis and why does it matter?

It is the time between the onset of psychotic symptoms and the start of adequate treatment. Longer durations have been associated with poorer response and outcome, which is the rationale for early detection and early intervention services.

References

  1. First Episode Psychosis Medical Workup: Evidence-Informed Recommendations and Introduction to a Clinically Guided Approach (opens in a new tab)Child Adolesc Psychiatr Clin N Am, 2020
  2. Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis: A Systematic Review and Meta-analysis (opens in a new tab)JAMA Psychiatry, 2023
  3. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin (opens in a new tab)Lancet Psychiatry, 2020
  4. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models (opens in a new tab)Lancet Neurol, 2019
  5. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations (opens in a new tab)Eur Arch Psychiatry Clin Neurosci, 2020
  6. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis (opens in a new tab)Schizophr Bull, 2016
  7. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis (opens in a new tab)Am J Psychiatry, 2005
  8. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies (opens in a new tab)Schizophr Bull, 2024
  9. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses (opens in a new tab)Lancet Psychiatry, 2017
  10. INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia (opens in a new tab)Lancet Psychiatry, 2025
  11. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology (opens in a new tab)J Psychopharmacol, 2020
  12. Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention (opens in a new tab)Am J Psychiatry, 2018